Gapping up
In reaction to strong earnings/guidance: UBNT +20.1%, ECOM +12.5%,SYMC +11.1% (also announces $500 mln strategic investment by Silver Lake, increases total capital return program to $5.5 bln), HIG +7.4%,PCTY +7.2%, TSN +4.4%, LITE +4.1%, PXLW +3.6%, MOBL +3.1%, SSD+3.1%, NTGR +3%, KIRK +2.4%, MTD +1.4%, ELY +1.3%, ELY +1.3%, TTMI+1.1%, SKYW +0.7%.
M&A news: MFLX +39.9% (Multi-Fineline to be acquired by Suzhou Dongshan Precision Manufacturing for $23.95 share in cash, BSI +18.5% (receives offer from the Zeevi Group to acquire 51% of BSI's outstanding shares from Alon Retail Ltd. for NIS 85 mln)
Select oil/gas related names showing strength: SDRL +7.8%, STO +4.8%,RDS.A +2.6%, CHK +1.2%, BP +1.2%, RIG +1.1%
Other news: SCLN +16.8% (SciClone announces final resolution with the Securities And Exchange Commission and The Department Of Justice),BCRX +6.6% (Baker Bros. boosts active stake to 20.5% (Prior 19.5%), GENE+2.7% (executes a Settlement and Release Agreement with Hendrix Genetics B.V.)
Analyst comments: GLUU +3% (upgraded to Buy at Benchmark), WFM+1.6% (upgraded to Neutral at Longbow)
In reaction to strong earnings/guidance: UBNT +20.1%, ECOM +12.5%,SYMC +11.1% (also announces $500 mln strategic investment by Silver Lake, increases total capital return program to $5.5 bln), HIG +7.4%,PCTY +7.2%, TSN +4.4%, LITE +4.1%, PXLW +3.6%, MOBL +3.1%, SSD+3.1%, NTGR +3%, KIRK +2.4%, MTD +1.4%, ELY +1.3%, ELY +1.3%, TTMI+1.1%, SKYW +0.7%.
M&A news: MFLX +39.9% (Multi-Fineline to be acquired by Suzhou Dongshan Precision Manufacturing for $23.95 share in cash, BSI +18.5% (receives offer from the Zeevi Group to acquire 51% of BSI's outstanding shares from Alon Retail Ltd. for NIS 85 mln)
Select oil/gas related names showing strength: SDRL +7.8%, STO +4.8%,RDS.A +2.6%, CHK +1.2%, BP +1.2%, RIG +1.1%
Other news: SCLN +16.8% (SciClone announces final resolution with the Securities And Exchange Commission and The Department Of Justice),BCRX +6.6% (Baker Bros. boosts active stake to 20.5% (Prior 19.5%), GENE+2.7% (executes a Settlement and Release Agreement with Hendrix Genetics B.V.)
Analyst comments: GLUU +3% (upgraded to Buy at Benchmark), WFM+1.6% (upgraded to Neutral at Longbow)